Literature DB >> 16917507

Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.

Yukiko Aikawa1, Lan Anh Nguyen, Kyoichi Isono, Nobuyuki Takakura, Yusuke Tagata, M Lienhard Schmitz, Haruhiko Koseki, Issay Kitabayashi.   

Abstract

Histone acetyltransferases (HATs) p300 and CREB-binding protein (CBP) function as co-activators for a variety of sequence-specific transcription factors, including AML1. Here, we report that homeodomain-interacting protein kinase-2 (HIPK2) forms a complex with AML1 and p300, and phosphorylates both AML1 and p300 to stimulate transcription activation as well as HAT activities. Phosphorylation of p300 is triggered by phosphorylated AML1 as well as by PU.1, c-MYB, c-JUN and c-FOS, and is inhibited by dominant-negative HIPK2. Phosphorylation of p300 and AML1 is impaired in Hipk1/2 double-deficient mouse embryos. Double-deficient mice exhibit defects in primitive/definitive hematopoiesis, vasculogenesis, angiogenesis and neural tube closure. These phenotypes are in part similar to those observed in p300- and CBP-deficient mice. HIPK2 also phosphorylates another co-activator, MOZ, in an AML1-dependent manner. We discuss a possible mechanism by which transcription factors could regulate local histone acetylation and transcription of their target genes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16917507      PMCID: PMC1560355          DOI: 10.1038/sj.emboj.7601273

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  49 in total

1.  CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter.

Authors:  D E Zhang; C J Hetherington; S Meyers; K L Rhoades; C J Larson; H M Chen; S W Hiebert; D G Tenen
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

2.  Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis.

Authors:  Q Wang; T Stacy; M Binder; M Marin-Padilla; A H Sharpe; N A Speck
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

3.  The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability.

Authors:  T Tanaka; M Kurokawa; K Ueki; K Tanaka; Y Imai; K Mitani; K Okazaki; N Sagata; Y Yazaki; Y Shibata; T Kadowaki; H Hirai
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

4.  Regulation of GM-CSF gene transcription by core-binding factor.

Authors:  P N Cockerill; C S Osborne; A G Bert; R J Grotto
Journal:  Cell Growth Differ       Date:  1996-07

5.  Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK.

Authors:  Chie Kanei-Ishii; Jun Ninomiya-Tsuji; Jun Tanikawa; Teruaki Nomura; Tohru Ishitani; Satoshi Kishida; Kenji Kokura; Toshihiro Kurahashi; Emi Ichikawa-Iwata; Yongsok Kim; Kunihiro Matsumoto; Shunsuke Ishii
Journal:  Genes Dev       Date:  2004-04-01       Impact factor: 11.361

6.  Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP.

Authors:  Qinghong Zhang; Yasuhiro Yoshimatsu; Jeffrey Hildebrand; Steven M Frisch; Richard H Goodman
Journal:  Cell       Date:  2003-10-17       Impact factor: 41.582

7.  Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha.

Authors:  E Ogawa; M Inuzuka; M Maruyama; M Satake; M Naito-Fujimoto; Y Ito; K Shigesada
Journal:  Virology       Date:  1993-05       Impact factor: 3.616

8.  Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions.

Authors:  S Meyers; J R Downing; S W Hiebert
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

9.  AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis.

Authors:  T Okuda; J van Deursen; S W Hiebert; G Grosveld; J R Downing
Journal:  Cell       Date:  1996-01-26       Impact factor: 41.582

10.  Phosphorylation of the adenovirus E1A-associated 300 kDa protein in response to retinoic acid and E1A during the differentiation of F9 cells.

Authors:  I Kitabayashi; R Eckner; Z Arany; R Chiu; G Gachelin; D M Livingston; K K Yokoyama
Journal:  EMBO J       Date:  1995-07-17       Impact factor: 11.598

View more
  66 in total

1.  Accelerated leukemogenesis by truncated CBF beta-SMMHC defective in high-affinity binding with RUNX1.

Authors:  Yasuhiko Kamikubo; Ling Zhao; Mark Wunderlich; Takeshi Corpora; R Katherine Hyde; Thomas A Paul; Mondira Kundu; Lisa Garrett; Sheila Compton; Gang Huang; Linda Wolff; Yoshiaki Ito; John Bushweller; James C Mulloy; P Paul Liu
Journal:  Cancer Cell       Date:  2010-05-18       Impact factor: 31.743

2.  PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation.

Authors:  Yutaka Shima; Takito Shima; Tomoki Chiba; Tatsuro Irimura; Pier Paolo Pandolfi; Issay Kitabayashi
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

Review 3.  Posttranslational modifications of RUNX1 as potential anticancer targets.

Authors:  S Goyama; G Huang; M Kurokawa; J C Mulloy
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

Review 4.  Cell cycle and developmental control of hematopoiesis by Runx1.

Authors:  Alan D Friedman
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

Review 5.  A role for RUNX1 in hematopoiesis and myeloid leukemia.

Authors:  Motoshi Ichikawa; Akihide Yoshimi; Masahiro Nakagawa; Nahoko Nishimoto; Naoko Watanabe-Okochi; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2013-04-24       Impact factor: 2.490

Review 6.  Posttranslational modifications regulate HIPK2, a driver of proliferative diseases.

Authors:  Vera V Saul; M Lienhard Schmitz
Journal:  J Mol Med (Berl)       Date:  2013-04-25       Impact factor: 4.599

Review 7.  Oncogene-induced senescence: an essential role for Runx.

Authors:  Anna Kilbey; Anne Terry; Ewan R Cameron; James C Neil
Journal:  Cell Cycle       Date:  2008-05-29       Impact factor: 4.534

8.  Modulation of the beta-catenin signaling pathway by the dishevelled-associated protein Hipk1.

Authors:  Sarah H Louie; Xiao Yong Yang; William H Conrad; Jeanot Muster; Stephane Angers; Randall T Moon; Benjamin N R Cheyette
Journal:  PLoS One       Date:  2009-02-02       Impact factor: 3.240

9.  SUMOylation regulates the nuclear mobility of CREB binding protein and its association with nuclear bodies in live cells.

Authors:  Colm M Ryan; Karin B Kindle; Hilary M Collins; David M Heery
Journal:  Biochem Biophys Res Commun       Date:  2009-12-16       Impact factor: 3.575

10.  HIPK2 modulates p53 activity towards pro-apoptotic transcription.

Authors:  Rosa Puca; Lavinia Nardinocchi; Ada Sacchi; Gideon Rechavi; David Givol; Gabriella D'Orazi
Journal:  Mol Cancer       Date:  2009-10-14       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.